Your browser doesn't support javascript.
loading
Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells.
Candas, Demet; Lu, Chung-Ling; Fan, Ming; Chuang, Frank Y S; Sweeney, Colleen; Borowsky, Alexander D; Li, Jian Jian.
Afiliação
  • Candas D; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California.
  • Lu CL; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California.
  • Fan M; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California.
  • Chuang FY; Center for Biophotonics, Science and Technology, University of California Davis School of Medicine, Sacramento, California. Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, California.
  • Sweeney C; Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Sacramento, California.
  • Borowsky AD; Center for Comparative Medicine, University of California Davis School of Medicine, Sacramento, California.
  • Li JJ; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California. NCI-designated Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, California. jijli@ucdavis.edu.
Cancer Res ; 74(24): 7498-509, 2014 Dec 15.
Article em En | MEDLINE | ID: mdl-25377473

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Fosfatase 1 de Especificidade Dupla Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Fosfatase 1 de Especificidade Dupla Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Res Ano de publicação: 2014 Tipo de documento: Article